SCHEMBL261022

SCHEMBL261022

O=C(O)c1ccc2scnc2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.74
RAB9A P51151 2/20 0.74
TDP1 Q9NUW8 2/20 0.74
KDM4E B2RXH2 1/20 0.74
HKDC1 Q2TB90 1/20 0.74
L3MBTL1 Q9Y468 1/20 0.74
SMN1; SMN2 Q16637 1/20 0.53
NAMPT P43490 1/20 0.52
HSD11B1 P28845 1/20 0.49
ESR1 P03372 2/20 0.47
CLK1 P49759 1/20 0.47
CLK2 P49760 1/20 0.47
CLK3 P49761 1/20 0.47
CRBN Q96SW2 5/20 0.46
DDB1 Q16531 3/20 0.44
FASN P49327 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HSD17B10 Q99714 1/20 0.44
DAO P14920 1/20 0.43
GFER P55789 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30917341 1.00 NPC1 (0.74) NPC1RAB9ATDP1KDM4EHKDC1
SCHEMBL27609695 0.98 NPC1 (0.72) NPC1RAB9ATDP1KDM4EHKDC1
SCHEMBL27609657 0.98 NPC1 (0.72) NPC1RAB9ATDP1KDM4EHKDC1
SCHEMBL8980158 0.86 KDM4E (0.61) NPC1RAB9ATDP1KDM4EHKDC1
SCHEMBL192332 0.85 NPC1 (1.00) NPC1RAB9ATDP1KDM4EHKDC1
Hydrochloric Acid SCHEMBL4255724 0.84 NPC1 (0.96) NPC1RAB9ATDP1KDM4EHKDC1
SCHEMBL10347638 0.84 NPC1 (0.96) NPC1RAB9ATDP1KDM4EHKDC1
SCHEMBL4155826 0.84 NPC1 (0.53) NPC1RAB9ATDP1KDM4EHKDC1
SCHEMBL17679198 0.84 NPC1 (0.53) NPC1RAB9ATDP1KDM4EHKDC1
SCHEMBL8861663 0.84 NPC1 (0.53) NPC1RAB9ATDP1KDM4EHKDC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 648 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118834382-A Preparation method of intrinsic antibacterial nylon based on end capping strategy 湘潭大学 2024-10-25 CN claimed
EP-3652164-B1 PHENYLACETAMIDES AS INHIBITORS OF ROCK BRISTOL MYERS SQUIBB CO (US) 2023-06-21 EP claimed
CN-111278817-B Polycyclic compounds as farnesol X receptor modulators 百时美施贵宝公司 2023-05-16 CN claimed
CN-115850173-A Naphthalimide compound and preparation method and application thereof 中国人民解放军陆军防化学院 2023-03-28 CN claimed
CN-107686284-B Composite material for caulking, repairing and waterproofing of concrete or inorganic plate 佛山科学技术学院 2020-03-20 CN claimed
CN-107399944-B A kind of flexible material modified portland cement encapsulation composite material 佛山科学技术学院 2019-12-03 CN claimed
CN-107399918-B A kind of Semi-rigid concrete composition FOSHAN UNIVERSITY (CN) 2019-10-29 CN claimed
CN-107686284-A It is a kind of to be used for concrete or inorganic plate filleting, repairing, the composite of waterproof 佛山科学技术学院 2018-02-13 CN claimed
CN-107399918-A A kind of Semi-rigid concrete composition 佛山科学技术学院 2017-11-28 CN claimed
CN-107399944-A A kind of flexible material modified portland cement encapsulates composite 佛山科学技术学院 2017-11-28 CN claimed
US-20130018043-A1 AMINOMETHYL QUINOLONE COMPOUNDS BILOTTA JOSEPH A (US) 2013-01-17 US claimed
EP-1102769-B1 TRICYCLIC CARBOXAMIDES SMITHKLINE BEECHAM PLC (GB) 2003-04-16 EP claimed
CN-1324359-A Tricyclic carboxamides SMITHKLINE BEECHAM PLC (GB) 2001-11-28 CN claimed
EP-1102769-A2 TRICYCLIC CARBOXAMIDES SMITHKLINE BEECHAM PLC (GB) 2001-05-30 EP claimed
WO-2000008020-A2 TRICYCLIC CARBOXAMIDES SMITHKLINE BEECHAM P.L.C. (GB) 2000-02-17 WO claimed
EP-0682663-A1 4-HYDROXY-BENZOPYRAN-2-ONES AND 4-HYDROXY-CYCLOALKYL B]PYRAN-2-ONES USEFUL TO TREAT RETROVIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 1995-11-22 EP claimed
EP-0271260-B1 Supersensitization of silver halide emulsions MINNESOTA MINING & MFG (US) 1995-01-04 EP claimed
US-4889796-A CONTAINING BENZOXAZOLE COMPOUND FUJI PHOTO FILM CO., LTD. (JP) 1989-12-26 US claimed
US-4873184-A ADDITION OF A METAL COMPLEXING AGENT TO THE EMULSION; HIGH SPEED MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1989-10-10 US claimed
EP-0271260-A2 Supersensitization of silver halide emulsions MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1988-06-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018043-A1 AMINOMETHYL QUINOLONE COMPOUNDS MAP3K1, MAP3K11, MAP3K5 NPC1 1624/4885RAB9A 1848/4885TDP1 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.